Back To Top

Tip: To quickly find your search term on this page, press "Ctrl" + "f" on your keyboard (Command + "f" on a Mac) and use the find bar.
Carboplatin Catalog#: A-2003
        
Cardiogenol C HCl Catalog#: A-1957
         Cardiogenol C is a diaminopyrimidine compound that induces the differentiation of MHC- (myosin heavy chain) positive cardiomyocytes from embryonic stem cells with an EC50 value of 0.1 µM.
CB-1158 Catalog#: A-6098
         CB-1158 is a selective Arginase inhibitor.
CB-5083 Catalog#: A-1513
         CB-5083 is an orally bioavailable inhibitor of valosin-containing protein (VCP) p97, with potential antineoplastic activity.
CC-115 Catalog#: A-1970
         CC-115 is a dual inhibitor of DNA-dependent protein kinase (DNA-PK) and mammalian target of rapamycin (mTOR), with potential antineoplastic activity.
CCT-007093 Catalog#: A-1346
         CCT007093 is a potent PPM1D inhibitor or WIP1 inhibitor that selectively reduces viability of human tumour cell lines
CCT-251545 Catalog#: A-1387
         a potent small-molecule inhibitor of WNT
CCT-251921 Catalog#: A-6003
         CCT-251921 is a potent selective inhibitor of the mediator complex-associated cyclin-dependent kinase CDK8 and CD19.
Cediranib(AZD-2171) Catalog#: A-1161
         Cediranib (tentative trade name Recentin), also known as AZD2171, is a potent inhibitor of vascular endothelial growth factor (VEGF) receptor tyrosine kinases.
Celecoxib Catalog#: A-9040
         Celecoxib is a highly selective COX-2 inhibitor and primarily inhibits prostaglandin production.
CEP-18770 Catalog#: A-1095
         CEP-18770 is a Proteasome inhibitor in clinical trials
CEP-32496 Catalog#: A-1310
         CEP-32496 is an oral small molecule kinase inhibitor of V600E mutated B-RAF.
CEP-37440 Catalog#: A-1300
         CEP-37440 is a selective dual ALK-FAK inhibitor, provided by Cephalon to determine the activity or response in potential clinical indications.
CEP-40783 Catalog#: A-6052
         CEP-40783 is a selective AXL inhibitor.
CEP-9722 Catalog#: A-1188
         CEP-9722 is a PARP inhibitor.
CFI-400945 (Free Base) Catalog#: A-6005
         CFI-400945 (Free Base) CFI-400945 is an a polo-like kinase 4 (PLK4) inhibitor with potential antineoplastic activity..
CGI-1746 Catalog#: A-1955
         CGI1746 is a small-molecule Btk inhibitor chemotype with a new binding mode that stabilizes an inactive nonphosphorylated enzyme conformation.
CGM-097 Catalog#: A-1315
         CGM-097 is a potent and selective MDM2 inhibitor.
CH-5132799 Catalog#: A-1215
         CH5132799, a novel class I PI3K inhibitor, exhibited a strong inhibitory activity especially against PI3Kα (IC(50)=0.014 μM).
CH-5424802 (RG-7853, AF-802) Catalog#: A-1176
         CH5424802 is a potent and selective ALK inhibitor
Chlorcyclizine.HCl Catalog#: A-9005
         Chlorcyclizine.HCl
CHR-3996 Catalog#: A-1082
         CHR-3996 is a HDAC inhibitor in clinical trials
CHS-828(GMX-1778) Catalog#: A-1954
         CHS-828, also known as GMX-1778, is a potent and selective NAMPT inhibitor.
CI-1033 Catalog#: A-1015
         CI-1033is an inhibitor of EGFR , HER-2 and ErbB-4
CI-1040(PD 184352) Catalog#: A-1064
         ATP-noncompetitive MEK inhibitor
CILENGITIDE Catalog#:
         Cilengitide is a cyclic arginine-glycine-aspartic acid peptide that targets avß3 integrin, expressed on neovasculature.
Cisplatin Catalog#: A-2004
        
CNX-1351 Catalog#: A-1337
         CNX-1351 is a selective covalent Inhibitor of PI3Kα
CO-1686 Catalog#: A-1621
         CO-1686 inhibits mutated EGFR including T790M, but ignores the wild type EGFR. CO-1686 shows promising clinical efficacy in patient tumors.
CP-1203 Catalog#: A-9065
         CP-1203 is a BET proteins inhibitor in preclinical development.
CP-868596 Catalog#: A-1519
         Crenolanib (CP-868596) is a potent and selective inhibitor of PDGFRα/β with Kd of 2.1 nM/3.2 nM in CHO cells, also potently inhibits FLT3, sensitive to D842V mutation not V561D mutation, >100-fold more selective for PDGFR than c-K
CPI-0610 Catalog#: A-1515
         CPI-0610 is a small molecule inhibitor of the Bromodomain and Extra-Terminal (BET) family of proteins, with potential antineoplastic activity.
CPI-203 Catalog#: A-1289
         CPI203 is a novel potent, selective and cell permeable inhibitor of the bromodomain and extra terminal (BET) family protein BRD4 with an IC50 of ~37 nM (BRD4 α-screen assay).
CPI-444 Catalog#: A-6099
         CPI-444 is a selective A2A inhibitor.
CPT-11 Catalog#: A-2005
         Inhibitor of DNA topoisomerase I that displays antitumor activity against a range of tumor types.
Curcumin Catalog#: A-1016
        
Cyclopamine Catalog#: A-1057
         Cyclopamine is a hegehog pathway inhibitor.

*Note: These products are for research purposes only, not for human consumption.